Dosimetric Evaluation of Incidental Irradiation to the Internal Mammary Chain After Surgery in Breast Cancer Patients

被引:1
|
作者
Wang, Wei [1 ]
Sun, Tao [2 ]
Meng, Yingtao [1 ]
Xu, Min [1 ]
Zhang, Yingjie [1 ]
Shao, Qian [1 ]
Song, Yuanfang [3 ]
Li, Jianbin [1 ]
机构
[1] Shandong First Med Univ & Shandong Acad Med Sci, Shandong Canc Hosp & Inst, Dept Radiat Oncol, Jinan, Peoples R China
[2] Shandong First Med Univ & Shandong Acad Med Sci, Shandong Canc Hosp & Inst, Dept Med Phys, Jinan, Peoples R China
[3] Shandong Univ, Wei Hai Municipal Hosp, Cheeloo Coll Med, Dept Radiat Oncol, Weihai, Peoples R China
来源
FRONTIERS IN ONCOLOGY | 2022年 / 12卷
基金
中国国家自然科学基金;
关键词
breast cancer; radiotherapy; radical mastectomy; breast-conserving surgery; internal mammary chain incidental irradiation dose; QUALITY-OF-LIFE; NODE IRRADIATION; RADIATION-THERAPY; DOSE DISTRIBUTION; LYMPH-NODES; RADIOTHERAPY; HEART; METAANALYSIS; NEOADJUVANT; MASTECTOMY;
D O I
10.3389/fonc.2022.839831
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Background and PurposeThe low rate of internal mammary node (IMN) recurrence was attributed to systemic therapy and internal mammary chain (IMC) coverage by the tangential fields of irradiation. This study aimed to evaluate the incidental irradiation dose to the IMC in breast cancer patients after surgery and to estimate the clinical predictive parameters affecting the magnitude of the IMC. Materials and MethodsA total of 138 patients treated with postmastectomy radiotherapy and 210 patients undergoing radiotherapy after breast-conserving surgery (BCS) in our hospital were retrospectively analyzed. The mean dose (Dmean) to the IMC and the first to third intercostal spaces of IMC levels (ICS1-3) were evaluated. We evaluated the IMC coverage according to the type of surgery and whether the ipsilateral supraclavicular fossa (SCF) was included in the irradiation field. ResultsThe incidental radiation dose to the IMC was 29.69 Gy, and the dose delivered to the IMC, ICS1, and ICS2 showed a greater coverage in the modified radical mastectomy (MRM) group when compared with the BCS group (32.85 vs. 27.1 Gy, 26.6 vs. 12.5 Gy, 34.63 vs. 30.42 Gy). The dose delivered to ICS3 showed no difference between the MRM and BCS groups (37.41 vs. 36.24 Gy). Furthermore, 131 patients (37.64%) received radiotherapy to the chest wall and ipsilateral SCF. In the univariate analysis, both surgery type and SCF irradiation were parameters affecting the Dmean of incidental radiation to the IMC (r = -0.179, P = 0.001; r = -0.175, P = 0.001). In the multivariate analysis, surgery type was the only correlative factor that affected incidental radiation dose to the IMC (r = -3.534, P = 0.000). ConclusionThe real influencing factor of incidental dose to the IMC was the surgery form rather than the accession of SCF irradiation.
引用
收藏
页数:7
相关论文
共 50 条
  • [1] Controversy about internal mammary chain irradiation in breast cancer
    Hennequin, C.
    Fourquet, A.
    CANCER RADIOTHERAPIE, 2014, 18 (5-6): : 351 - 355
  • [2] Clinical audit of breast cancer patients treated with helical tomotherapy for irradiation of the internal mammary chain
    Shrivastav, Garima
    Datta, Debanjali
    Wadasadawala, Tabassum
    Rane, Pallavi
    Panda, Subhajit
    Pathak, Rima
    Scaria, Libin
    Krishnamurthy, Revathy
    Sarin, Rajiv
    JOURNAL OF RADIOTHERAPY IN PRACTICE, 2022, 22
  • [3] Internal mammary chain irradiation in breast cancer: State of the art
    Auberdiac, P.
    Cartier, L.
    Chargari, C.
    Desbat, N. -H. Hau
    Zioueche, A.
    Melis, A.
    Kirova, Y. -M.
    de Laroche, G.
    Magne, N.
    CANCER RADIOTHERAPIE, 2011, 15 (02): : 148 - 153
  • [4] Lymphoscintigraphy Can Select Breast Cancer Patients for Internal Mammary Chain Radiotherapy
    Hindie, Elif
    Groheux, David
    Hennequin, Christophe
    Zanotti-Fregonara, Paolo
    Vercellino, Laetitia
    Berenger, Nathalie
    Toubert, Marie-Elisabeth
    Maylin, Claude
    Vilcoq, Jacques-Robert
    Espie, Marc
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2012, 83 (04): : 1081 - 1088
  • [5] Helical tomotherapy for locoregional irradiation including the internal mammary chain in left-sided breast cancer: Dosimetric evaluation
    Caudrelier, Jean-Michel
    Morgan, Scott C.
    Montgomery, Lynn
    Lacelle, Manon
    Nyiri, Balazs
    MacPherson, Miller
    RADIOTHERAPY AND ONCOLOGY, 2009, 90 (01) : 99 - 105
  • [6] Dosimetric comparison of incidental axillary irradiation between three-dimensional conformal and volumetric modulated arc techniques for breast cancer
    Jo, In Young
    Kim, Eun Seog
    Kim, Woo Chul
    Min, Chul Kee
    Yeo, Seung-Gu
    MOLECULAR AND CLINICAL ONCOLOGY, 2020, 12 (06) : 551 - 556
  • [7] Dosimetric Evaluation of 3-D Conformal and Intensity-modulated Radiotherapy for Breast Cancer after Conservative Surgery
    Mansouri, Safae
    Naim, Asmaa
    Glaria, Luis
    Marsiglia, Hugo
    ASIAN PACIFIC JOURNAL OF CANCER PREVENTION, 2014, 15 (11) : 4727 - 4732
  • [8] Unplanned irradiation of internal mammary lymph nodes in breast cancer
    Kanyilmaz, Gul
    Aktan, Meryem
    Koc, Mehmet
    Demir, Hikmettin
    Demir, Lutfi Saltuk
    RADIOLOGIA MEDICA, 2017, 122 (06): : 405 - 411
  • [9] Geometrical and dosimetrical evaluation of different interpretations of a european consensus delineation guideline for the internal mammary lymph node chain in breast cancer patients
    Buhl, Emma Skarso
    Wortel, Geert
    Simoes, Rita
    Scholten, Astrid
    Offersen, Birgitte Vrou
    Korreman, Stine
    Janssen, Tomas
    PHYSICS & IMAGING IN RADIATION ONCOLOGY, 2024, 32
  • [10] Cardiovascular disease incidence after internal mammary chain irradiation and anthracycline-based chemotherapy for breast cancer
    Boekel, Naomi B.
    Jacobse, Judy N.
    Schaapveld, Michael
    Hooning, Maartje J.
    Gietema, Jourik A.
    Duane, Frances K.
    Taylor, Carolyn W.
    Darby, Sarah C.
    Hauptmann, Michael
    Seynaeve, Caroline M.
    Baaijens, Margreet H. A.
    Sonke, Gabe S.
    Rutgers, Emiel J. T.
    Russell, Nicola S.
    Aleman, Berthe M. P.
    van Leeuwen, Flora E.
    BRITISH JOURNAL OF CANCER, 2018, 119 (04) : 408 - 418